Yantai Dongcheng Bio(002675.SZ) subsidiary, Lanna Cheng, has obtained the license for production of radioactive pharmaceuticals.

Yantai Dongcheng Biochemicals (002675.SZ) announced that recently, the company received a notification from its controlling subsidiary Yantai Lannacheng Biotechnology Co., Ltd. ("Lannacheng") that it has obtained a "Radiopharmaceutical Production License" issued by the Shandong Provincial Drug Administration. The acquisition of the "Drug Production License" by Lannacheng is expected to have no significant impact on the company's current performance. The commercial production of Fluoride [18F] sirtopeptide injection can proceed after obtaining the drug marketing approval number.